United Kingdom Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others
Summary
GlobalData’s “United Kingdom Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others
The United Kingdom Orthobiologics Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2023 company share and distribution share data for Orthobiologics Market.
- Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United Kingdom Orthobiologics is segmented as follows -
- Bone Grafts and Substitutes
- Bone Growth Stimulators
- Cartilage Repair
- Soft Tissue Biologics
- Viscosupplementation
The United Kingdom Orthobiologics Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Orthobiologics Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Orthobiologics Market, United Kingdom
- 3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033
- 3.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
- 3.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.3 Orthobiologics Market, United Kingdom, Average Price ($) , 2018-2033
- 3.4 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2023
- 3.5 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2023
- 4 Overview of Key Companies in United Kingdom, Orthobiologics Market
- 4.1 Medtronic Plc
- 4.1.1 Company Overview
- 4.2 Sanofi
- 4.2.1 Company Overview
- 4.3 Stryker Corp
- 4.3.1 Company Overview
- 4.4 ZimVie Inc
- 4.4.1 Company Overview
- 4.5 Orthofix Holdings Inc
- 4.5.1 Company Overview
- 4.6 Bioventus Inc
- 4.6.1 Company Overview
- 4.7 Fidia farmaceutici SpA
- 4.7.1 Company Overview
- 4.8 Globus Medical Inc
- 4.8.1 Company Overview
- 4.9 Zimmer Biomet Holdings Inc
- 4.9.1 Company Overview
- 5 Orthobiologics Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Acquisition
- 6.1.1 Lifco to Acquire Ortho-Care UK
- 6.2 Debt Offerings
- 6.2.1 Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
- 6.2.2 Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
- 7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
- 7.1.2 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting
- 7.2 Financial Announcements
- 7.2.1 Sep 10, 2024: Tissue Regenix Group Announces Interim Results for Six Months Ended June 30, 2024
- 7.3 Strategy And Business Planning
- 7.3.1 Apr 25, 2024: Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1B Clinical Trial in Multiple Myeloma
- 8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- List of Tables
- Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
- Table 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
- Table 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
- Table 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
- Table 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
- Table 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
- Table 13: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
- Table 14: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023
- Table 15: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023
- Table 16: Orthobiologics Market Pipeline Products
- Table 17: Lifco to Acquire Ortho-Care UK
- Table 18: Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
- Table 19: Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
- Table 20: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
- List of Figures
- Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
- Figure 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
- Figure 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
- Figure 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
- Figure 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
- Figure 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
- Figure 13: Orthobiologics Market, United Kingdom, Company Share (%) 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook